MC3 Recorded Education Series: ADHD in Pregnancy
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
- Participants will be able to preform assessments of pregnant patients with ADHD (Attention Deficit Hyperactivity Disorder) to determine which patients may benefit from continuing stimulant therapy.
- Participants will be able to recognize the symptoms of untreated ADHD in pregnant patients and intervene to address their needs.
- Learners will be able to effectively communicate with and educate patients about the risks and benefits of taking ADHD medications in pregnancy.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Original Release Date: September 2020
Termination Date: September 2023
Baker, A. S., & Freeman, M. P. (2018). Management of Attention Deficit Hyperactivity Disorder During Pregnancy. Obstet Gynecol Clin N Am, 45, 495–509.
Buoli, M., Serati, M., & Cahn, W. (2016). Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Review of Neurotherapeutics 16 (2), 133-144.
Ustun, B., Adler, L. A., Rudin, C., Faraone, S. V., Spencer, T. J., Berglund, P., ... Kessler, R. C. (2017). The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry, 74(5).